INTERNATIONAL PATENT: LASSEN THERAPEUTICS, INC. FILES APPLICATION FOR "DOSING OF ANTI-IL-11RΑ ANTIBODIES IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS"

GENEVA, Dec. 17 -- LASSEN THERAPEUTICS, INC. (5510 Morehouse Drive, Suite 100San Diego, California 92121) filed a patent application (PCT/US2025/032681) for "DOSING OF ANTI-IL-11RAlpha ANTIBODIES IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS" on Jun 06, 2025. With publication no. WO/2025/255486, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SWANEY, James Stephen (c/o Lassen Therapeutics, Inc.5510 Morehouse Drive, Suite 100San Diego, California 92121), FARDIS, Maria (c/o Lassen Therapeutics, Inc.5510 Morehouse Drive,...